Disable ads (and more) with a premium pass for a one time $4.99 payment
Receiving a mydriatic medication during an eye exam leads to dilation of the pupils, which can significantly impair vision, especially in terms of the ability to focus clearly and sensitivity to light. Individuals may experience blurred vision and difficulty seeing objects up close, as well as increased glare from bright lights, which can severely hinder driving ability.
Because of these vision impairments, it is advisable not to drive until the effects of the medication have worn off fully. While other options suggest waiting or relying on personal judgment regarding one's ability, such assessments may overlook the potential risks involved, making it unsafe to drive post-examination. Therefore, the position stating that vision will be impaired after receiving mydriatic medication is valid and highlights the importance of ensuring safe practices following such procedures.